Brief: Onxeo To Present New Preclinical Data At AACR 2021

Valerio Therapeutics SA

08/04/2021 17:11

April 8 (Reuters) - ONXEO SA  ALONX.PA :
    * ONXEO TO PRESENT NEW PRECLINICAL DATA AT AACR 2021
    * CONFIRMING EFFECT OF ASIDNA™ ON RESISTANCE TO KRAS
INHIBITORS
    * INTRODUCING OX400, A NEW GENERATION OF PARP INTERFERING
CANCER
DRUG CANDIDATES

Source text for Eikon:  ID:nBw9k0RCPa 
Further company coverage:  ALONX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))